Gilead Sciences
Price & Volume
Stats
See more52W Range | $80.42-$120.98 |
Market Cap | $137.7B |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $28.8B |
Revenue Growth (YoY) | 1.8% |
Gross Profit (12 Mos) | $22.6B |
Diluted EPS | $5.04 |
News
See moreYahoo Finance • 5 days ago
Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
Yahoo Finance • 5 days ago
Did Gilead's (GILD) $32 Billion AI Bet Just Transform Its Innovation and Global Health Narrative?
Yahoo Finance • 7 days ago
Trump considering website for consumers to buy discounted prescription drugs - report
Yahoo Finance • 11 days ago
Alger Russell Innovation Index Updates for Third Quarter 2025
About
CEO | Mr. Daniel P. O'Day |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,600 |
